Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) were up 6.9% on Friday . The company traded as high as $0.3554 and last traded at $0.3420. Approximately 20,077 shares were traded during trading, an increase of 18% from the average daily volume of 16,946 shares. The stock had previously closed at $0.32.
Alpha Tau Medical Trading Up 6.9%
The business has a 50-day moving average of $0.33 and a two-hundred day moving average of $0.28.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Featured Stories
- Five stocks we like better than Alpha Tau Medical
- CD Calculator: Certificate of Deposit Calculator
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- Election Stocks: How Elections Affect the Stock Market
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- What is a Microcap Stock? Everything You Need to Know
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
